CLCSCell SourceCLCS info
$0.43info-24.56%24h
Global rank28473
Market cap$16.57M
Change 7d-14.00%
YTD Performance7.50%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Cell Source (CLCS) Stock Overview

    Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. Cell Source, Inc. was incorporated in 2012 and is headquartered in New York, New York.

    CLCS Stock Information

    Symbol
    CLCS
    Address
    57 West 57th StreetNew York, NY 10019United States
    Founded
    -
    Trading hours
    -
    Website
    https://cell-source.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    646 416 7896

    Cell Source (CLCS) Price Chart

    -
    Value:-

    Cell Source Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.43000001
    N/A
    Market Cap
    $16.57M
    N/A
    Shares Outstanding
    38.55M
    N/A
    Employees
    1.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org